- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: OPC-34712
Total 241 results
-
Organon and CoCompleted
-
Bial - Portela C S.A.Completed
-
McNeil ABCompleted
-
Yale UniversityViiV HealthcareNot yet recruiting
-
Michael HoelscherRadboud University Medical Center; University College, London; University of...RecruitingTuberculosis, Pulmonary | Other Specified Pulmonary TuberculosisSouth Africa, Tanzania
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Bial - Portela C S.A.CompletedParkinson's Disease
-
University of MiamiStandard Process Inc.CompletedSub-optimal Cognitive Function | Sub-optimal Immune FunctionUnited States
-
National Institute of Allergy and Infectious Diseases...ViiV HealthcareActive, not recruitingHIV InfectionsThailand, United States, Botswana, Uganda, South Africa
-
Bial - Portela C S.A.CompletedParkinson's DiseaseRomania, Ukraine
-
Bial - Portela C S.A.Completed
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Bipolar DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedTourette's Disorder (TD)United States, Canada, Hungary
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/S; PRA Health SciencesCompletedSchizophrenia | Bipolar I DisorderUnited States
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Otsuka Pharmaceutical Co., Ltd.CompletedBipolar I DisorderTaiwan, Korea, Republic of, Japan, China
-
Bial - Portela C S.A.CompletedParkinson's DiseasePortugal
-
Otsuka Pharmaceutical Co., Ltd.CompletedMajor Depressive DisorderJapan
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.CompletedParkinson DiseasePortugal
-
Otsuka Pharmaceutical Co., Ltd.CompletedBipolar I DisorderTaiwan, Korea, Republic of, Japan, China
-
Otsuka Pharmaceutical Co., Ltd.CompletedBipolar I DisorderTaiwan, Korea, Republic of, Japan, China
-
Bial - Portela C S.A.Completed
-
Seoul National University HospitalKorea Otsuka Pharmaceutical Co., Ltd.CompletedSchizophreniaKorea, Republic of
-
Otsuka Pharmaceutical Development & Commercialization...PRA Health SciencesCompletedSchizophrenia | Bipolar I DisorderUnited States
-
Bial - Portela C S.A.CompletedParkinson's Disease (PD)France
-
Bial - Portela C S.A.CompletedParkinson's DiseasePortugal, Romania, Ukraine
-
Bial - Portela C S.A.Completed
-
SanofiCompletedEmbolism | ThrombosisUnited States, France, Canada, Brazil, Poland, Ukraine, Italy, Netherlands, Portugal, Spain, Sweden, Turkey, Bulgaria, Estonia, India, Philippines, Belgium, Czech Republic, Mexico, Argentina, Croatia, Denmark, Egypt, Israel, Norway, United... and more
-
University Hospital of FerraraCompletedParkinson Disease | Effect of DrugItaly
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedALSUnited States, Netherlands, Canada, Italy, Spain, Belgium, France, Germany, Hungary, Israel
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Major Depressive Disorder | Mental Disorder | Bipolar I DisorderUnited States
-
Médecins Sans Frontières, FranceHarvard Medical School (HMS and HSDM); Institute of Tropical Medicine, Belgium and other collaboratorsCompletedTuberculosis, Multidrug-Resistant | Infection, Bacterial | Pulmonary TuberculosesPakistan, Georgia, India, Kazakhstan, Lesotho, Peru, South Africa
-
Bial - Portela C S.A.CompletedParkinson's Disease (PD)France
-
Bial - Portela C S.A.CompletedParkinson DiseaseCanada
-
Otsuka Pharmaceutical Development & Commercialization...Terminated
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)United States, Australia, Bulgaria, Romania, India, Slovakia, Philippines
-
Baodong QinRecruiting
-
University of California, Los AngelesNational Institute of Neurological Disorders and Stroke (NINDS)CompletedStrokeCanada, United States
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisGermany